Movatterモバイル変換


[0]ホーム

URL:


CN106011249A - Method for batch identification of circular RNAs and application of circular RNAs - Google Patents

Method for batch identification of circular RNAs and application of circular RNAs
Download PDF

Info

Publication number
CN106011249A
CN106011249ACN201610392217.0ACN201610392217ACN106011249ACN 106011249 ACN106011249 ACN 106011249ACN 201610392217 ACN201610392217 ACN 201610392217ACN 106011249 ACN106011249 ACN 106011249A
Authority
CN
China
Prior art keywords
circular rna
rna
primer
circular
circ
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610392217.0A
Other languages
Chinese (zh)
Inventor
杨展
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to CN201610392217.0ApriorityCriticalpatent/CN106011249A/en
Publication of CN106011249ApublicationCriticalpatent/CN106011249A/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

At present, most of databases, such as circular RNAs listed in circBase and the like, are based on bioinformatics prediction or gene sequencing results, and real existence and expression of some circular RNAs in concrete cells or tissues cannot be completely responded. Therefore, when some circular RNAs are studied, firstly cells and tissues are needed to be identified. However, if a single circular RNA is identified, identification does not come out because of differences of cells or tissues or diseases, and at the time, interested RNAs are needed to be screened in force. Through obtaining of the circular RNA sequences and design of specific primers, the circular RNAs are identified in batches. The method is low in cost and high in accuracy, most importantly, can be used for batch detection, and is an optimal method for fundamental researches and application researches.

Description

A kind of batch identifies method and the application thereof of circular rna
Technical field
The invention belongs to molecular biology research field, involved range of application includes that inside and outside batch is identified ring-typeThe basic research of RNA molecule and follow-up as biomarker for Clinical detection and the application of diagnosis.It is specially batch mirrorDetermine method and the application thereof of circular rna.
Background technology
Circular rna (circular RNA, circRNA) is the RNA (non-coding that the class recently confirmed is specialRNA, ncRNA) molecule, the RNA molecule being generally cyclized by part of exon or intron, thus its structure compares ordinary linesShape RNA is stable.CircRNA is prevalent in eukaryotic cell, has certain tissue, sequential and disease specific.CircRNA isOne nova risen the most potential of RNA family, is also the up-to-date study hotspot in RNA field.In early days, closeDocument in circRNA is reported few, and expression is relatively low, therefore in a very long time, circRNA is considered as wrongThe side-product missing alternative splicing (alternative splicing) and formed, belongs to the rarest phenomenon of one in nature,Even it is taken as heredity surprisingly or to test caused by anthropic factor, does not cause academic attention.Along with RNA order-checking and biological letterThe fast development of the technology such as breath, people find when broad scale research transcript profile data, and circRNA is thought before being not asAs be the rarest phenomenon of one, be present in the most in a large number in eukaryotic cell.Danan etc. find, circRNA is at ArchimycetesCell generally exists, and thinks that it very likely has biological function.Meanwhile, Salzman etc. also confirm that circRNA is peopleClass cellular gene expression is a universal phenomenon, and the key player of various biological function may be play.Jeck etc. adoptUse high-flux sequence method, detect more than 25000 kinds of circRNA in human fibroblasts, it is believed that circRNA is RNAThe conservative product of the class stabilizer pole formed after shearing, additionally, it is observed that circRNA can be by small interfering RNA (smallInterfering RNA, siRNA) degraded.The research such as Memczak confirms that circRNA participates in post-transcriptional control, HansenDeng research then disclose circRNA and can affect regulation and control and the expression of gene as miRNA sponge (miRNA sponge).
Although circRNA is found existing more than 30 years, but due to reasons such as technical limitations, circRNA be constantly in byThe status that academia is ignored.But it is along with in recent years about the discovery of several breakthrough researchs of circRNA, the most internationally famousAuthority publication Nature delivers two papers about circRNA biological function, shocks academia, pulls open from this and openThe prelude of circRNA Mysterious Veil, circRNA has caused the concern of domestic and international academia, and will start research boom.AndGlazar etc. establish circRNA private database " circBase ", this data base circRNA money to having delivered at presentExpect to carry out integrating unified, that offer is known and new simultaneously circRNA order-checking data, it is intended to the research for circRNA providesOne preferable intercommunion platform.
But, at present mostly data base, the circular rna as listed by circBase etc. is all based on Bioinformatics PredictionOr the result of gene sequencing, and can not for some circular rna necessary being in concrete cell or tissue and expressionReact completely.Therefore we are when studying some circular rna it may first have to it is carried out cell and tissue characterization.But, ifIndividually certain circular rna is identified, probably due to cell or tissue or the difference of disease and can not identify out, the most justRNA interested in us is needed to carry out substantial amounts of examination.The present invention is by the acquisition of circular rna sequence and special primerDesign thus in batches these circular rnas are identified.
Summary of the invention
CircRNA be after genetic transcription RNA montage process formed, thus cyclisation connecting portion structural dna sequence andComposition can't detect in genome.
First, we are by finding the possible DNA sequence of certain circular rna from gene bank, then by design a pair evenConnecing the reverse primer (Divergent primers) near part, we are named circ-XXX-F and circ-XXX-R.CarefullyThe RNA product (cDNA) of born of the same parents or tissue can detect that, and the PCR process with genomic DNA as template can't detect.PCRResult detects through agarose gel electrophoresis result, is positive for template with cDNA, and is negative with genomic DNA for template, i.e.It may be circular rna;Both are negative or the positive is not circular rna.
Secondly, circular rna is circulus because of it, by designing a pair reverse primer at its gene internal, after PCRExpanding out by whole circular RNA molecule, further order-checking just can obtain the gene order of circular rna.Accordingly, it is determined that the first stepAfter, we will design a pair primer (Convergent primers) in the same direction, and we are named Linear-XXX-F and Linear-XXX-R.Linear-XXX-F and circ-XXX-R of these primers, or circ-XXX-F and Linear-XXX-R needs part weightFolded.
Then carrying out PCR amplification with cDNA for template, PCR result detects through agarose gel electrophoresis result, to be predictedMolecular size range consistent after, PCR primer is checked order, finally determines circular RNA molecule sequence.
Technical solution of the present invention example:
From 12 circular rnas of circBase random choose, after finding their sequence, separately design primer with DNAstar software,Specific as follows:
BARD1 hsa_circ_0001098
circR-BARD1-F:CTGACTTTCTTACTTCGAGGGCTAAAC
circR-BARD1-R:GGTATCAAAATGACTCACCACTTCACG
PRKD3 hsa_circ_0000992
circR-PRKD3-as-F:CATTCTGGGGGGATGAACTTTTC
circR-PRKD3-as-R:GGAACTGTCTTTATCTGCTGTCAAGG
RSF1 hsa_circ_0000345
circ-RSF1-as-F:CACAGTAGTCTCTTCTAGAACATTGGC
circ-RSF1-as-R:CCTTCCAAACCATCCTGAGC
CBL hsa_circ_0000363
circ-CBL-F:CACAAATGGAGCCCAGACCAG
circ-CBL-R:CCAGAACTGATGGGATGCACTTC
APLF hsa_circ_0001023
circ-APLF-F:GTGGGCCAAGATGAGACTGATG
circ-APLF-R:GATTCGCAGCTGACCACCTG
MGAT5 hsa_circ_0001068
circ-MGAT5-F: GGTACATCAAGGCACTGGCAGAAG
circ-MGAT5-R: GAAAATGGTAGCAGGATCTTGAAGC
BTBD7 hsa_circ_0000563
circ-BTBD7-as-F:GCACCCATTTTCTTCAGTCACTCAG
circ-BTBD7-as-R:GGCAGAAGAAGCCATGGAACTTTAC
KPNB1 hsa_circ_0000780
circ-KPNB1-F:CCTGTTAAGGATGTTCCAAAGCAC
circ-KPNB1-R:CTTCACCAGATTCTGTAAAGCAGCC
CNTRL hsa_circ_0001884
circR-CNTRL-F:CTTCAGGTTGTTTTAAGGCAGATGTC
circR-CNTRL-R:CTCCGACTGCCGCTTGGATG
LYN hsa_circ_0001803
circ-LYN-F:GCCATGGGATAAAGATGCCTG
circ-LYN-R:CATCGTCACTCAAGCTGTCTTTCC
The extraction of total serum IgE (with reference to Total mRNA Extract kit (Omiga) workbook, specific as follows:
(1) 293T that 80%-90% merges, rinses gently with 1 × PBS twice, fully removes unnecessary liquid, add 1 mLRNA lysate (RNA-Solv), cell is blown down by room temperature;
(2) homogenate is transferred to 1.5 mL without in the EP of RNase and add the chloroform of 200 μ L, acutely after concussion 15 seconds on iceStand 10 min;
(3) after significantly layering occurs in homogenate, putting into 4 DEG C 12,000 g is centrifuged 15 min, and at this moment homogenate just can divideIt it is three layers;
(4) careful transfer upper strata aqueous phase (less than 80 % of upper strata cumulative volume) is in new EP without a RNase pipe, and addsThe dehydrated alcohol of 1/2 times of volume, fully mixing 15 seconds;
(5) being transferred to by mixing liquid in HiBind RNA centrifugal column, room temperature 10,000 g is centrifuged 1 min, abandons effluent;, (6)Being positioned in new collecting pipe by centrifugal column, and the RNA adding 300 μ L washes miscellaneous buffer I, 10,000 g are centrifuged 30 seconds, abandonRemove effluent;
(7) again adding 400 μ L RNA in centrifugal column and wash miscellaneous buffer I, 10,000 g are centrifuged 1 min, discard effluent;(8) washing miscellaneous buffer II toward the RNA adding 500 μ L dehydrated alcohol dilutions in centrifugal column, 10,000 g are centrifuged 1 min, abandonEffluent;
(9) after repeating (8) washing, 13,000 g are centrifuged 2 min and fully remove residual liquid;
(10) centrifugal column is placed in 1.5 new mL without in RNase centrifuge tube, centrifugal column adds 30 μ L DEPC water, room temperatureAfter standing 2 min, 13,000 g are centrifuged 1 min, again suck back in centrifugal column by eluate, and repeated centrifugation once, is finally collectedEluent ,-80 DEG C of preservations.
The qualification of RNA is with quantitative: take the RNA solution of 2 l gained, in 1 % agarose gel electrophoresis, at detection of nucleic acids instrumentLower observation RNA integrity, 28S, 18S band is complete, clear, and 28S brightness is 2 times of 18S, and preservation of taking a picture, and shows RNAComplete without degraded.Separately take 2 l RNA solution, carry out quantitatively at nucleic acid quantification instrument, obtained RNA concentration, OD 260/280 ratioIn the range of 1.8-2.0, show that the RNA purity of gained is higher, reach the requirement of next step experiment.
Reverse transcription reaction and process take the total serum IgE of the 5 above-mentioned gained of μ g, operate according to M-MLV First Strand KitHandbook reverse transcription synthesis cDNA, reaction system is 20 l.Specifically comprise the following steps that
(1) in 0.2 mL microcentrifugal tube of RNase, add the total serum IgE of 1 μ g, oligo (dT) 1 μ L and 10 mM dNTP1 μ L, then moisturizing is to 12 μ L, centrifugal mixes rear 65 DEG C of degeneration 5 min, is immediately placed in cooled on ice, of short duration centrifugal after respectivelyAdd 4 μ L 5 × the first chain synthesis buffer, 2 μ L 0.1 M DTT and 1 L RNaseOUT nucleic acid inhibitor;
(2) centrifugal mixing, is subsequently placed in PCR reaction instrument 37 DEG C and hatches 2 min, add 1 μ L M-MLV subsequently inverse under room temperatureTranscriptase (200 U/ μ L), centrifugal mixing;
(3) placing back in PCR instrument, pre-set programs 37 DEG C reaction 50 min, then 70 DEG C process 15 min to inactivate reverseRecord enzyme, last 4 DEG C of coolings.Preparation cDNA be saved in-20 DEG C standby.
PCR expands circular rna fragment concrete steps:
(1) on ice, primer, cDNA/gDNA template and 5 X PCR buffer are melted;
(2) 50 μ LPCR reaction systems (PrimeSTAR HS DNA Polymerase, Code are prepared by following descriptionNo.: R010A).(5 X PCR buffer, 10 μ L;Primerstar PCR enzyme, 0.5 μ L;DNTP Mix, 4 μL;Primers F, 2 μ L;Primers R, 2 μ L;GDNA template, 1 μ L (50 ng);DdH2O, 30.5 μ L;) totalTotally 50 μ L;
(3) by the most centrifugal for mixed box liquid, reacting in PCR instrument, condition is as follows: (98 DEG C, 3 min;98 DEG C, 15 s;68 ℃, 45 s;68 DEG C, 2 min;Totally 34 cycles) last 4 DEG C of preservations;
(4) 5 μ L PCR product are taken in 2 % DNA agarose gel electrophoresiies, 120 V, 15 min, note of taking pictures under uviol lampRecord;
(5) selecting may be for the gene of circular rna, and standard is: be positive with cDNA for template, and with genomic DNA as templateIt is negative, it is possible to for circular rna;And person is negative or the positive is not circular rna.
According to the above results, separately design following primer with DNAstar software, wherein underscore for newly synthesized, do not haveHave underscore for original primer, specific as follows:
BARD1 hsa_circ_0001098
linearR-BARD1-F:GAAGTGGTGAGTCATTTTGATACCCG
circR-BARD1-R:GGTATCAAAATGACTCACCACTTCACG
PRKD3 hsa_circ_0000992
linearR-PRKD3-as-F:GCTTCAATGGTAACACTCTCCCG
circR-PRKD3-as-R:GGAACTGTCTTTATCTGCTGTCAAGG
RSF1 hsa_circ_0000345
circ-RSF1-as-F:CACAGTAGTCTCTTCTAGAACATTGGC
linearR-RSF1-as-R:CTTGTGAAACTGCCAGTCATAGTGAAGC
CBL hsa_circ_0000363
circ-CBL-F:CACAAATGGAGCCCAGACCAG
linearR-CBL-R:GCAATGAAAATGGAAGTGAGTGCC
APLF hsa_circ_0001023
linearR-APLF-F:CACACAAATCCATGTTTTTACCAGTC
circ-APLF-R:GATTCGCAGCTGACCACCTG
MGAT5 hsa_circ_0001068
circ-MGAT5-F: GGTACATCAAGGCACTGGCAGAAG
linearR-MGAT5-R: CTGCTTTCAGGCTGAGTTCGC
BTBD7 hsa_circ_0000563
linearR-BTBD7-as-F:CCTGGTCATGTTTGGCTTCC
circ-BTBD7-as-R:GGCAGAAGAAGCCATGGAACTTTAC
KPNB1 hsa_circ_0003650
circ-KPNB1-F:CCTGTTAAGGATGTTCCAAAGCAC
linearR-KPNB1-R:CTGAAGAGTTGCACAGAGTAAAGACTGAAG
CNTRL hsa_circ_0001884
linearR-CNTRL-F:GCGGGAAGAAAGGTGGATGAG
circR-CNTRL-R:CTCCGACTGCCGCTTGGATG
LYN hsa_circ_0001803
circ-LYN-F:GCCATGGGATAAAGATGCCTG
linearR-LYN-R:CCAATCTTCTGCACAAGCCATC。
PCR expands circular rna fragment concrete steps:
(1) on ice, primer, cDNA template and 5 X PCR buffer are melted;
(2) 50 μ LPCR reaction systems (PrimeSTAR HS DNA Polymerase, Code are prepared by following descriptionNo.: R010A).(5 X PCR buffer, 10 μ L;Primerstar PCR enzyme, 0.5 μ L;DNTP Mix, 4 μL;Primers F, 2 μ L;Primers R, 2 μ L;GDNA template, 1 μ L (50 ng);DdH2O, 30.5 μ L;) totalTotally 50 μ L;
(3) by the most centrifugal for mixed box liquid, reacting in PCR instrument, condition is as follows: (98 DEG C, 3 min;98 DEG C, 15 s;68 ℃, 45 s;68 DEG C, 2 min;Totally 34 cycles) last 4 DEG C of preservations;
(4) 5 μ L PCR product are taken in 2 % DNA agarose gel electrophoresiies, 120 V, 15 min, note of taking pictures under uviol lampRecord;
(5) PCR result detects through agarose gel electrophoresis result, after band position is consistent with the molecular size range of prediction,PCR primer is checked order, finally determines circular RNA molecule sequence;
(6) PCR primer reclaims and sample presentation carries out gene sequencing.
Result and analysis:
Due to we design primer detection fragment all between 100-250 bp, agarose gel electrophoresis such as Fig. 1 institute after PCRShowing, in this regional extent, the sequence of circular rna junction can detect in c (cDNA) template group, and at g (genomic DNA)Template detection less than, can tentatively judge the existence of this circular rna, we have seen that from result, such as BARD1, PRKD3,RSF1, CBL, APLF, MGAT5, BTBD7, KPNB1, CNTRL have significantly band in region.And CBL is due to equal in c and g groupThere is band, it is likely that for non-specific, need next step PCR to determine.Next full genome is expanded by we with linear primer.
Result is as in figure 2 it is shown, PRKD3, and RSF1, CBL, APLF, MGAT5, BTBD7 all can detect relatively bright band,Compared with prediction stripe size, PRKD3 about 943 pb, RSF1 about 1982 bp, APLF about 1190 bp, BTBD7 about 1268 bp,And CBL and MGAT5 becomes clear, pillar location and prediction is inconsistent, is not likely to be circular rna to be detected.CNTRL, MGAT5 are thenMore non-specific band occurs, is also regarded as can not be detected.We carry out gene survey after the recovery of bright band for next stepSequence, in order to finally determine whether the circular rna detected by us.
Through gene sequencing result, sequence is consistent with the circular rna sequence of prediction, such as Fig. 3, shown in 4,5,6.
In sum, the present invention is a kind of method that batch quickly detects circular rna, first, to circular rna interestedFirst synthesizing the primer circ-XXX-F/R of its junction, whether PCR detection junction exists in batches, if there is after, then setCount one group of linear Yu circ-XXX-F/R and there is partly overlapping primer, through PCR, whole circular rna is expanded, after through surveyingSequence determines its sequence accuracy.
Accompanying drawing illustrates:
Fig. 1 circular rna junction primer circ-XXX-F/R is through PCR batch Preliminary detection, and the region between dotted line is 100-The fragment of 250 bp sizes, detects with c (cDNA) template group in this region, and in g (genomic DNA) template detectionLess than band may be i.e. circular rna;
The full-length gene PCR result of Fig. 2 circular rna, screens the gene of obvious band from Fig. 1, design one group of linear withThere is partly overlapping primer in circ-XXX-F/R, it is ring-type that what PCR result was similar with the size that predicts the outcome is i.e. likely to thisRNA;
Fig. 3 circular rna PRKD3(hsa_circ_0000992) full length fragment sequencing result;
Fig. 4 circular rna RSF1(hsa_circ_0000345) full length fragment sequencing result;
Fig. 5 circular rna APLF(hsa_circ_0001023) full length fragment sequencing result;
Fig. 6 circular rna BTBD7(hsa_circ_0000563) full length fragment sequencing result.

Claims (10)

CN201610392217.0A2016-06-062016-06-06Method for batch identification of circular RNAs and application of circular RNAsPendingCN106011249A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN201610392217.0ACN106011249A (en)2016-06-062016-06-06Method for batch identification of circular RNAs and application of circular RNAs

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN201610392217.0ACN106011249A (en)2016-06-062016-06-06Method for batch identification of circular RNAs and application of circular RNAs

Publications (1)

Publication NumberPublication Date
CN106011249Atrue CN106011249A (en)2016-10-12

Family

ID=57089542

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN201610392217.0APendingCN106011249A (en)2016-06-062016-06-06Method for batch identification of circular RNAs and application of circular RNAs

Country Status (1)

CountryLink
CN (1)CN106011249A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN107190073A (en)*2017-06-262017-09-22中国人民解放军第八医院Applications of the hsa_circRNA_104907 in the diagnosis, treatment and prognosis of Down syndrome
CN108192959A (en)*2018-04-012018-06-22南京千年健干细胞基因工程有限公司A kind of gene detecting kit of the identification mesenchymal stem cell passage number based on circular rna
CN108192958A (en)*2018-04-012018-06-22南京千年健干细胞基因工程有限公司A kind of gene detecting kit of the identification umbilical cord mesenchymal stem cells passage number based on circular rna
CN110846391A (en)*2019-07-232020-02-28中山大学孙逸仙纪念医院Detection method of full-length sequence of circular RNA
CN115896101A (en)*2022-10-262023-04-04江苏省人民医院(南京医科大学第一附属医院)Protein translated by circular RNA molecule and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
包纯: ""一类新非编码RNA的发现以及产生和功能的初探",A006-01", 《中国博士学位论文全文数据库 基础科学辑》*

Cited By (8)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN107190073A (en)*2017-06-262017-09-22中国人民解放军第八医院Applications of the hsa_circRNA_104907 in the diagnosis, treatment and prognosis of Down syndrome
CN107190073B (en)*2017-06-262020-12-15中国人民解放军第一八一医院Application of hsa _ circRNA _104907 in diagnosis, treatment and prognosis of Down syndrome
CN108192959A (en)*2018-04-012018-06-22南京千年健干细胞基因工程有限公司A kind of gene detecting kit of the identification mesenchymal stem cell passage number based on circular rna
CN108192958A (en)*2018-04-012018-06-22南京千年健干细胞基因工程有限公司A kind of gene detecting kit of the identification umbilical cord mesenchymal stem cells passage number based on circular rna
CN110846391A (en)*2019-07-232020-02-28中山大学孙逸仙纪念医院Detection method of full-length sequence of circular RNA
CN110846391B (en)*2019-07-232024-03-19中山大学孙逸仙纪念医院Method for detecting full-length sequence of circular RNA
CN115896101A (en)*2022-10-262023-04-04江苏省人民医院(南京医科大学第一附属医院)Protein translated by circular RNA molecule and application thereof
CN115896101B (en)*2022-10-262023-12-05江苏省人民医院(南京医科大学第一附属医院) A protein translated by circular RNA molecules and its application

Similar Documents

PublicationPublication DateTitle
Holla et al.Positioning heterochromatin at the nuclear periphery suppresses histone turnover to promote epigenetic inheritance
Babaian et al.Loss of m1acp3Ψ ribosomal RNA modification is a major feature of cancer
CN106011249A (en)Method for batch identification of circular RNAs and application of circular RNAs
Yamazaki et al.Functional domains of NEAT1 architectural lncRNA induce paraspeckle assembly through phase separation
Reyes et al.Mitochondrial DNA replication proceeds via a ‘bootlace’mechanism involving the incorporation of processed transcripts
Achsel et al.A doughnut‐shaped heteromer of human Sm‐like proteins binds to the 3′‐end of U6 snRNA, thereby facilitating U4/U6 duplex formation in vitro
Haller et al.In vitro selection of a 7-methyl-guanosine binding RNA that inhibits translation of capped mRNA molecules
Rasche et al.Cwc2 and its human homologue RBM22 promote an active conformation of the spliceosome catalytic centre
EP3830262A1 (en)Nuclei barcoding and capture in single cells
US20170009304A1 (en)Method and kit for detecting fusion transcripts
CN104830867A (en)Aptamer capable of being specifically combined with DKK1 protein in cancer cells
Han et al.DNA-directed termination of RNA polymerase II transcription
WO2009130176A9 (en)Antiviral therapy
Xie et al.Progression through the spliceosome cycle requires Prp38p function for U4/U6 snRNA dissociation
CN105132409B (en)The library constructing method of RNA 5mC bisulfites sequencing and its application
WO2009034055A1 (en)Method for predicting the response of a subject suffering from a viral infection of the liver to an antiviral therapy
ES2360113T3 (en) UNIVERSAL AMPLIFICATION OF FRAGMENTED RNA.
Cheng et al.Plasma membrane associated transcription of cytoplasmic DNA
Nieto et al.Efficient fractionation and analysis of ribosome assembly intermediates in human cells
EP2917363A1 (en)Means and methods for identifying ribosome associated rna molecules
CN107475441B (en) A biomarker for predicting responsiveness to neoadjuvant chemotherapy with AT regimen in breast cancer patients
Massie et al.Global identification of androgen response elements
AU2006314369A1 (en)Method for diagnosticating hepatic diseases and for screening molecules for treating said diseases
Luce et al.Minimizing false positives in differential display
CN105779640A (en)miRNA biomarker and detection kit used for renal cancer diagnosis

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
WD01Invention patent application deemed withdrawn after publication
WD01Invention patent application deemed withdrawn after publication

Application publication date:20161012


[8]ページ先頭

©2009-2025 Movatter.jp